Literature DB >> 25755458

Chronic hepatitis B virus infection and pregnancy.

Manoj Kumar1, Tarandeep Singh1, Swati Sinha2.   

Abstract

Planning of pregnancy and management of chronic hepatitis B virus during pregnancy includes recognition of maternal virological status, assessment of liver disease severity and minimization of risk for mother to infant transmission of infection. Decisions regarding the use of antivirals during pregnancy need to be individualized. Monitoring for infection and immunization in newborns is also important. For mothers on antiviral therapy, breastfeeding is not recommended.

Entities:  

Keywords:  ALT, alanine aminotransferase; APASL, Asian Pacific Association for the Study of the Liver; APR, Antiretroviral Pregnancy Registry; CDC, Centers for Disease Control and Prevention; CI, confidence interval; DART, Development of Antiretroviral Therapy Study; EASL, European Association for the Study of the Liver; ECS, elective caesarian section; FDA, Food and Drug Administration; HBIg, hepatitis B immunoglobulin; HBV, hepatitis B virus; HBeAg, hepatitis B e antigen; HBsAg, hepatitis B surface antigen; HIV, human immunodeficiency virus; NA, nucleot(s)ide analog; PEG-IFN, pegylated interferon; PHACS, Pediatric HIV/AIDS Cohort Study; RCTs, randomized clinical trials; breast feeding; chronic hepatitis B; pregnancy

Year:  2012        PMID： 25755458      PMCID： PMC3940289          DOI： 10.1016/j.jceh.2012.09.001

Source DB:  PubMed          Journal:  J Clin Exp Hepatol        ISSN： 0973-6883


  129 in total

1.  Concentrations of tenofovir and emtricitabine in breast milk of HIV-1-infected women in Abidjan, Cote d'Ivoire, in the ANRS 12109 TEmAA Study, Step 2.

Authors:  Sihem Benaboud; Alain Pruvost; Patrick A Coffie; Didier K Ekouévi; Saïk Urien; Elise Arrivé; Stéphane Blanche; Frédéric Théodoro; Divine Avit; François Dabis; Jean-Marc Tréluyer; Déborah Hirt
Journal:  Antimicrob Agents Chemother       Date:  2010-12-20       Impact factor: 5.191

2.  The maternal-fetal transfer of lamivudine in the ex vivo human placenta.

Authors:  S L Bloom; K M Dias; R E Bawdon; L C Gilstrap
Journal:  Am J Obstet Gynecol       Date:  1997-02       Impact factor: 8.661

3.  Postpartum subsidence of hepatitis B viral replication in HBeAg-positive carrier mothers.

Authors:  H H Lin; P J Chen; D S Chen; J L Sung; K H Yang; Y C Young; Y S Liou; Y P Chen; T Y Lee
Journal:  J Med Virol       Date:  1989-09       Impact factor: 2.327

4.  Pregnancy and chronic hepatitis B virus infection.

Authors:  Swati Sinha; Manoj Kumar
Journal:  Hepatol Res       Date:  2010-01       Impact factor: 4.288

5.  Moderation of breastfeeding effects on the IQ by genetic variation in fatty acid metabolism.

Authors:  Avshalom Caspi; Benjamin Williams; Julia Kim-Cohen; Ian W Craig; Barry J Milne; Richie Poulton; Leonard C Schalkwyk; Alan Taylor; Helen Werts; Terrie E Moffitt
Journal:  Proc Natl Acad Sci U S A       Date:  2007-11-05       Impact factor: 11.205

6.  Hepatitis B virus genotypes in children and adolescents in Japan: before and after immunization for the prevention of mother to infant transmission of hepatitis B virus.

Authors:  Ayano Inui; Haruki Komatsu; Tsuyoshi Sogo; Toshiro Nagai; Kenji Abe; Tomoo Fujisawa
Journal:  J Med Virol       Date:  2007-06       Impact factor: 2.327

7.  Effect of hepatitis B immunoglobulin on interruption of HBV intrauterine infection.

Authors:  Xiao-Mao Li; Min-Feng Shi; Yue-Bo Yang; Zhong-Jie Shi; Hong-Ying Hou; Hui-Min Shen; Ben-Qi Teng
Journal:  World J Gastroenterol       Date:  2004-11-01       Impact factor: 5.742

Review 8.  Review: protective efficacy of hepatitis B vaccines in neonates.

Authors:  F E André; A J Zuckerman
Journal:  J Med Virol       Date:  1994-10       Impact factor: 2.327

9.  Risk of hepatitis B transmission in breast-fed infants of chronic hepatitis B carriers.

Authors:  James B Hill; Jeanne S Sheffield; Matthew J Kim; James M Alexander; Barbara Sercely; George D Wendel
Journal:  Obstet Gynecol       Date:  2002-06       Impact factor: 7.661

10.  Incidence of cancer in children perinatally exposed to nucleoside reverse transcriptase inhibitors.

Authors:  Valérie Benhammou; Josiane Warszawski; Stéphanie Bellec; François Doz; Nicolas André; Brigitte Lacour; Martine Levine; Françoise Bavoux; Roland Tubiana; Laurent Mandelbrot; Jacqueline Clavel; Stéphane Blanche
Journal:  AIDS       Date:  2008-10-18       Impact factor: 4.177
View more
  9 in total

1.  Hepatobiliary quiz-5 (2013).

Authors:  Swastik Agrawal; Radha K Dhiman
Journal:  J Clin Exp Hepatol       Date:  2013-03

2.  Early childhood transmission of hepatitis B prior to the first hepatitis B vaccine dose is rare among babies born to HIV-infected and non-HIV infected mothers in Gulu, Uganda.

Authors:  E Seremba; J P Van Geertruyden; R Ssenyonga; C K Opio; J M Kaducu; J B Sempa; R Colebunders; P Ocama
Journal:  Vaccine       Date:  2017-04-20       Impact factor: 3.641

3.  Association between maternal hepatitis B virus carrier and gestational diabetes mellitus: a retrospective cohort analysis.

Authors:  Fang He; Dunjin Chen; Wanchang Yin; Bingjun Chen; Yilin Yang; Xiuzi Li; Ruirui Li; Jiangnan Xie; Guixian Chen
Journal:  Virol J       Date:  2021-11-20       Impact factor: 4.099

4.  Prevalence and knowledge of hepatitis B infection in pregnant women in a primary health center of Patna district, Bihar.

Authors:  Sanjay Pandey; Pallavi Lohani; Ria Roy; Ditipriya Bhar; Alok Ranjan; Pragya Kumar; C M Singh
Journal:  J Family Med Prim Care       Date:  2021-11-05

5.  Viral Load Pattern Among Hepatitis B Surface Antigen-positive Patients: Laboratory Perspective and Implications for Therapy.

Authors:  K C Iregbu; P I Nwajiobi-Princewill
Journal:  Ann Med Health Sci Res       Date:  2016 Mar-Apr

6.  Serological positive markers of hepatitis B virus in femoral venous blood or umbilical cord blood should not be evidence of in-utero infection among neonates.

Authors:  Lei Zhang; Xi-En Gui; Bo Wang; Jing-Yi Fan; Qian Cao; Kathleen Mullane; Xiao-Li Liang
Journal:  BMC Infect Dis       Date:  2016-08-12       Impact factor: 3.090

7.  Prevalence and risk factors of hepatitis B infection among mothers and children with hepatitis B infected mother in upper Dolpa, Nepal.

Authors:  Purusotam Raj Shedain; Madhu Dixit Devkota; Megha Raj Banjara; Huang Ling; Subash Dhital
Journal:  BMC Infect Dis       Date:  2017-10-10       Impact factor: 3.090

8.  Efficacy of tenofovir in preventing perinatal transmission of HBV infection in pregnant women with high viral loads.

Authors:  Yayun Lin; Yan Liu; Guifeng Ding; Lhousseine Touqui; Weimin Wang; Na Xu; Keying Liu; Lingyan Zhang; Dunjin Chen; Yongzheng Wu; Guiqin Bai
Journal:  Sci Rep       Date:  2018-10-19       Impact factor: 4.379

9.  Prevalence and Knowledge of Hepatitis B Virus Infection among Pregnant Women in the Ningo-Prampram District, Ghana.

Authors:  Precious Kwablah Kwadzokpui; Elliot Elikplim Akorsu; Albert Abaka-Yawson; Solomon Sosu Quarshie; Stephen Adomako Amankwah; Philip Apraku Tawiah
Journal:  Int J Hepatol       Date:  2020-04-27
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.